Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study

BACKGROUND: Calprotectin is a biomarker of disease activity in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) and predicts relapse in juvenile idiopathic arthritis. Higher drug trough serum levels are associated with a good response in patients treated with tumor necrosis factor inhibitors...

Full description

Saved in:
Bibliographic Details
Published in:Arthritis Res Ther
Main Authors: Inciarte-Mundo, José, Ramirez, Julio, Hernández, Maria Victoria, Ruiz-Esquide, Virginia, Cuervo, Andrea, Cabrera-Villalba, Sonia Raquel, Pascal, Mariona, Yagüe, Jordi, Cañete, Juan D., Sanmarti, Raimon
Format: Artigo
Language:Inglês
Published: BioMed Central 2018
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292085/
https://ncbi.nlm.nih.gov/pubmed/30545393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-018-1764-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items